Europe Antacids Market value was worth USD 3.99 billion in 2019 and estimated to be growing at a CAGR of 4.3%, to reach USD 4.93 billion by 2024 during the forecast period 2019-2024.
Europe Antacids are a group of medications that helps in neutralize the content of acid reflux in the stomach. It provides fast relief of heartburn, one of the main symptoms of gastroesophageal reflux digestion and other symptoms are nausea, bloating or belching. Antacids include magnesium carbonate, aluminium hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids incorporate magnesium carbonate, aluminium hydroxide, and magnesium trisilicate. A few people have announced unfavourably susceptible responses to antacids.
The growing trend toward self-medication is increasing the demand for over-the-counter digestive products for the treatment of gastrointestinal disorders. Antacids are used to neutralize acidity and should therefore cause a dramatic increase in demand. According to a study conducted by the American Gastroenterological Association and published in the International Functional Foundation in February 2017, about one-third of the US population. Suffering from GERD. Market restraints include some side effects such as constipation, laxative effect and allergic reactions. In addition, people suffering from certain medical conditions are prone to adverse effects that worsen their state of health because people with heart disease may have problems due to the high amount of sodium present in antacids.
Europe Antacid Market segmented and sub-segmented into the following categories and evaluated market size and forecast until 2024
By Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, And Pro-motility Agents
By Formulation Type: Tablet, Liquid And Powder
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Others.
By Country: France, Germany, Italy, Spain and UK.
By geography the market is segmented into UK, Spain, Germany, France and others. It is occupying last second place in terms of market share. Among them UK and Germany are occupied highest share. German has many investments compared to other regions.
Some of the Prominent Companies leading the Europe Antacid Market Profiled in the Report are:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Submarkets
5.1.1 Introduction
5.1.2 Chromatography
5.1.3 E-Clinical Trial Solutions
5.1.4 Wireless Health, Clinical Trial Management Systems(CTMS)
5.1.5 Healthcare IT outsourcing
5.1.6 Immunoassay
5.1.7 Digital Pathology
5.1.8 Next Generation sequencing(NGS)
5.1.9 Proteomics
5.1.10 Magnesium Compounds
5.1.11 , Aluminium Compounds
5.1.12 Calcium Compounds
5.1.13 Antacids with Antiflatulents
5.1.14 Y-o-Y Growth Analysis, By Submarkets
5.1.15 Market Attractiveness Analysis, By Submarkets
5.1.16 Market Share Analysis, By Submarkets
5.2 Application
5.2.1 Introduction
5.2.2 Novel Dietary Fibers
5.2.3 Y-o-Y Growth Analysis, By Application
5.2.4 Market Attractiveness Analysis, By Application
5.2.5 Market Share Analysis, By Application
5.3 Ingredients
5.3.1 Introduction
5.3.2 Protease
5.3.3 Modified Starch
5.3.4 Food & Beverage Starch
5.3.5 Gellatin
5.3.6 Collagen
5.3.7 Carbohydrase
5.3.8 Food & Beverage Sugars & its substitutes
5.3.9 Y-o-Y Growth Analysis, By Ingredients
5.3.10 Market Attractiveness Analysis, By Ingredients
5.3.11 Market Share Analysis, By Ingredients
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Submarkets
6.1.3.3 By Application
6.1.3.5 By Ingredients
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Submarkets
6.1.4.3 By Application
6.1.4.4 By Ingredients
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Submarkets
6.1.5.3 By Application
6.1.5.4 By Ingredients
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 First Aid Only
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GSK
8.3 WellSpring Pharm
8.4 Private Lable
8.5 Pfizer
8.6 Procter & Gamble
8.7 Glaxosmithkline
8.8 Boehringer Ingellheim Pharm
8.9 Novaritis Consurmer Health
8.10 Johnson & Johnson
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
